The authors suggested PON2 as a new modulator of glucose transport and pharmacologically tractable pathways necessary for tumor growth and metastasis of PDAC, and thus a novel target to attenuate tumor growth and metastasis. This evidence concerns the gene PON2 and neoplasm.